IACP Continues to Work with Major Media Outlets
The Wall Street Journal
IACP's David G. Miller, RPh, EVP/CEO quoted regarding the Compromise Compounding Bill in The Wall Street Journal article (9.28.13), "House Passes Bill Regulating Specialty Pharmacies: Effectiveness of Legislation Still Questioned."
Read more here.
IACP is quoted in a Bloomberg Businessweek article (9.27.13) on the Compromise Compounding Bill, "A Confusing Attempt to Cure Compounding Pharmacies." Read more here.
"On Friday the International Academy of Compounding Pharmacists, the industry’s politically potent trade group, vowed to fight the proposed legislation. 'This bill, in its failure to recognize the very real problems in the draft legislation that we have identified over many meetings, will without question result in patients’ inability to obtain access to needed medications,' David Miller, the academy’s chief executive, said in an e-mailed statement. 'Although states have long had sufficient authority to regulate compounding, the bill grants the FDA sweeping, unprecedented authority in determining what pharmacies can compound.'”
IACP's David G. Miller, RPh, and IACP Board Member Pat Stephens, PharmD, Medi-Fare Drug & Home Health Center, Inc., in Blacksburg, S.C., worked with the NPR affiliate, WFAE, to explain how the current FDA inspections are using cGMP compliance standards that were not designed for compounding pharmacies.
Click here, to view and listen to the NPR broadcast, "FDA Inspections Put Compounding Pharmacies in Regulatory Gray Zone."
"Very few of the compounders inspected have met the FDA's manufacturer standards. That's no surprise to David Miller, the CEO of the International Academy of Compounding Pharmacists. 'The federal government has changed the rules and inspected with a different rule book, and then told them that they can't do business unless they follow rules that were never designed for a pharmacy in the first place,'" Miller said.
IACP is continuing to work with the media on behalf of its membership to Protect, Promote & Advance Pharmacy Compounding.